Literature DB >> 23517868

Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

.   

Abstract

In February 2013, novel coronavirus (nCoV) infection was diagnosed in an adult male in the United Kingdom with severe respiratory illness, who had travelled to Pakistan and Saudi Arabia 10 days before symptom onset. Contact tracing identified two secondary cases among family members without recent travel: one developed severe respiratory illness and died, the other an influenza-like illness. No other severe cases were identified or nCoV detected in respiratory samples among 135 contacts followed for 10 days.

Entities:  

Mesh:

Year:  2013        PMID: 23517868     DOI: 10.2807/ese.18.11.20427-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  96 in total

1.  The legacies of SARS - international preparedness and readiness to respond to future threats in the Western Pacific Region.

Authors:  John S Mackenzie; Angela Merianos
Journal:  Western Pac Surveill Response J       Date:  2013-07-02

2.  Underlying trend, seasonality, prediction, forecasting and the contribution of risk factors: an analysis of globally reported cases of Middle East Respiratory Syndrome Coronavirus.

Authors:  Omar B Da'ar; Anwar E Ahmed
Journal:  Epidemiol Infect       Date:  2018-06-11       Impact factor: 2.451

3.  International Health Regulations (2005) facilitate communication for in-flight contacts of a Middle East respiratory syndrome case, Hong Kong Special Administrative Region, 2014.

Authors:  Poon Kwok-ming; Wong Miu-ling; Leung Yiu-hong; Sin Ka-wai; To May-kei Liza; Chuang Shuk-kwan
Journal:  Western Pac Surveill Response J       Date:  2015-03-26

Review 4.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Family clusters of avian influenza A H7N9 virus infection in Guangdong Province, China.

Authors:  Lina Yi; Dawei Guan; Min Kang; Jie Wu; Xianqiao Zeng; Jing Lu; Shannon Rutherford; Lirong Zou; Lijun Liang; Hanzhong Ni; Xin Zhang; Haojie Zhong; Jianfeng He; Jinyan Lin; Changwen Ke
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

Review 6.  MERS coronavirus: diagnostics, epidemiology and transmission.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Virol J       Date:  2015-12-22       Impact factor: 4.099

7.  Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.

Authors:  Lanying Du; Guangyu Zhao; Zhihua Kou; Cuiqing Ma; Shihui Sun; Vincent K M Poon; Lu Lu; Lili Wang; Asim K Debnath; Bo-Jian Zheng; Yusen Zhou; Shibo Jiang
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

Authors:  Raoul J de Groot; Susan C Baker; Ralph S Baric; Caroline S Brown; Christian Drosten; Luis Enjuanes; Ron A M Fouchier; Monica Galiano; Alexander E Gorbalenya; Ziad A Memish; Stanley Perlman; Leo L M Poon; Eric J Snijder; Gwen M Stephens; Patrick C Y Woo; Ali M Zaki; Maria Zambon; John Ziebuhr
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Debate on MERS-CoV respiratory precautions: surgical mask or N95 respirators?

Authors:  S J Chung; M L Ling; W H Seto; B S Ang; P A Tambyah
Journal:  Singapore Med J       Date:  2014-06       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.